Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-24 Purchase |
2022-06-28 7:15 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
10,000 | $1.0134 | $10,135 | 1,385,119 (Indirect Direct) |
View |
2022-06-02 Purchase |
2022-06-06 6:43 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
5,890 | $0.98424 | $5,797 | 1,375,119 (Indirect Direct) |
View |
2022-03-31 Purchase |
2022-04-01 4:18 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
15,000 | $1.6356 | $24,534 | 1,369,229 (Indirect Direct) |
View |
2022-03-16 Purchase |
2022-03-17 7:10 pm |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
49,038 | $1.5711 | $77,045 | 248,444 (Indirect) |
View |
2022-03-15 Purchase |
2022-03-17 7:09 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
30,000 | $1.4867 | $44,600 | 1,354,229 (Indirect Direct) |
View |
2021-09-30 Sale |
2021-10-01 7:39 pm |
Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner |
5,000,000 | $5.012 | $25,059,900 | 81,077 (Indirect) |
View |
2021-09-20 Sale |
2021-09-22 5:27 pm |
Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner |
1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) |
View |
2021-09-20 Sale |
2021-09-22 5:24 pm |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) |
View |
2021-08-20 Purchase |
2021-08-23 9:01 pm |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
10,000 | $1.9254 | $19,254 | 1,324,229 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-08-11 Option Award |
2022-08-15 6:49 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:47 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:44 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
160,000 | $0 | 160,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:44 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:40 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
320,000 | $0 | 320,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:39 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:39 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:37 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:36 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
2022-08-11 Option Award |
2022-08-15 6:20 pm |
N/A 2032-08-11 |
Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner |
15,000 | $0 | 3,290,616 (Indirect) |
View |
2022-06-15 Option Award |
2022-06-17 9:31 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 9:27 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:37 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:35 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 6,958,654 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:26 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:26 pm |
N/A 2032-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-09-22 3:30 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,081,077 (Indirect) |
View |
2021-09-09 Option Award |
2021-09-13 5:00 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD President and CEO |
320,000 | $0 | 320,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:59 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:57 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks |
160,000 | $0 | 160,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:56 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:55 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:53 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner |
15,000 | $0 | 3,290,616 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:53 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 8,068,298 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:51 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:48 pm |
N/A 2031-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-09-09 Option Award |
2021-09-13 4:02 pm |
N/A 2021-09-09 |
Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner |
15,000 | $0 | 3,290,616 (Indirect) |
View |
2021-06-15 Option Award |
2021-06-16 4:19 pm |
N/A 2031-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:19 pm |
N/A 2031-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:18 pm |
N/A 2031-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-15 Option Award |
2021-06-16 4:17 pm |
N/A 2031-06-15 |
Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director |
15,000 | $0 | 15,000 (Direct) |
View |